Results 201 to 210 of about 363,419 (348)

Toll-like receptor 2 deficiency exacerbates corneal angiogenesis in injury by impairing regulatory T cells. [PDF]

open access: yesTheranostics
Ko JH   +9 more
europepmc   +1 more source

Maintaining trust in uncertain times: Funding pauses and the ethical cost to community‐engaged research

open access: yesAmerican Journal of Community Psychology, EarlyView.
Abstract Federal funding pauses, once considered rare, are increasingly disrupting the stability and continuity of community‐engaged research. Even projects with active, awarded grants are experiencing the strain of funding uncertainty, raising substantive concerns among research teams and community partners. These disruptions extend beyond operational
Brynn E. Sheehan
wiley   +1 more source

Toll-like receptor 2 activation of early divided bovine embryo promotes its viability and development competence in vitro. [PDF]

open access: yesSci Rep
Ma D   +7 more
europepmc   +1 more source

Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer? [PDF]

open access: yesInt J Mol Sci, 2023
Majewski M   +7 more
europepmc   +1 more source

TOLL-LIKE RECEPTOR 2, 4 AND 9 GENETIC VARIANTS IN MEXICAN PATIENTS WITH AMOEBIC LIVER ABSCESS

open access: gold, 2013
Oswaldo Partida‐Rodríguez   +14 more
openalex   +1 more source

Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis

open access: gold, 2023
Alshaymaa M. Alhabibi   +14 more
openalex   +2 more sources

Toll-like receptor 2 (TLR2); CD14 [PDF]

open access: yesScience-Business eXchange, 2013
openaire   +1 more source

Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Sickle cell disease (SCD) is a chronic inflammatory state, characterized by increased plasma values of inflammatory and angiogenic proteins. Although red blood cell (RBC) transfusion is known to have immunomodulatory effects in other conditions, its potential effects on the inflammatory state in SCD remain largely unknown.
Lydian A. de Ligt   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy